Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: PARP Inhibitor BGB-290
Total 0 results
Nothing found
Sponsors and Collaborators
Ensemble contre le SIDA
Rubens da Silva
Hospital Geral de Fortaleza
University of Illinois at Urbana-Champaign
BioMAdvanced Diagnostics
Philip Spinella
JSR Medical Co., Ltd.
Providence Public School District
BRUSANO
Jiangyin Hospital Affiliated to Southeast University School of Medicine
Prof. Jacques SCHRENZEL
Medical Group Care, LLC
Orthopaedic Biomechanics and Biomaterials Laboratory at Massachusetts General Hospital
Henriette Svarre Nielsen, Professor Dept. of Obstetrics and Gynecology, Hvidovre Hospital
Douglas Kwon
Depression and Bipolar Support Alliance
Sanfilippo Children's Research Foundation
PTC Therapeutics
Depressie Vereniging (patient association)
Villanova University
View Full List
Medical Conditions
Age-related Hearing Loss
Post Covid-19 Condition
Social Anxiety
Extraarticular Fracture
Renal Function Disorder
Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use
Artificial Pancreas
Decay
Dislocation, Shoulder
Accuracy and Precision of Noninvasive Measurement
Neck Mass
Anaplastic Large-cell Lymphoma
PD-1 Refractory Advanced Melanoma
Hospital Acquired Pressure Ulcer
Sporadic
Anatomic Stage 2A Breast Cancer AJCC v8
Surgical Patient
LOW OVARIAN RESPONSE
Optimys Femoral Stem
STEMI - ST-segment Elevation Myocardial Infarction
View Full List
Drug Interventions
THC
Intravenous Formulation of PD-0332991
Olopatadine
Intravenous deferiprone
Fospropofol disodium, propofol
Capecitabine and IMRT (if randomized to this arm)
Letrozole
Camptosar
Desvenlafaxine
Standard of care (SOC) for COVID-19
RDX227675
Capecitabine/cisplatin
GLPG1837 multiple ascending doses
Anticholinergic
PD-1/PD-L1 inhibitor
OnabotulinumtoxinA
MLN2480
Oxycodone/acetaminophen 5/325 mg
TPN-101
Midazolam
View Full List
CROs by country
Contract Research Organizations in Bangladesh
Contract Research Organizations in Benin
Contract Research Organizations in Burundi
Contract Research Organizations in Cyprus
Contract Research Organizations in Gambia
Contract Research Organizations in Greece
Contract Research Organizations in Ireland
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Mozambique
Contract Research Organizations in Myanmar
Contract Research Organizations in Oman
Contract Research Organizations in Sweden
Contract Research Organizations in Vietnam
CRO list by country
CROs in Iran
Farzan Clinical Research
SGS
All CROs in Iran
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe